Fair Value Calculator Fair Value Calculator
EN DE

ACL (ACL) Fair Value & Analysis

Basic Materials · Market cap ₹4.8B

A ACL ACL · NSE
Price₹52.03
Fair Value₹5.87
Upside-88.7%
Quality34/100
Watch ACL for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹4.38 – ₹8.76

Fair value as of: Jul 3, 2026

From 2 valuation models · updated today

Share price −4.3% over the past month.

Price vs Fair Value (12 months)

₹104.76 ₹40.79 Fair Value ₹5.87 Jul 2025 Jul 2026

12‑month range ₹40.79 – ₹104.76 · fair‑value band ₹4.38 – ₹8.76 · the ₹52.03 price screens above the ₹5.87 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ACL (ACL) currently trades at ₹52.03, while our model-based Fair Value estimate is ₹5.87 — implying the stock looks roughly 88.7% overvalued today. We read business quality at 34/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, ACL generated revenue of ₹4.4B at a net margin of -15.2%. Revenue grew 73.2% year over year. It earns a return on equity of -59.6%. Net debt stands at ₹11.2B. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹4.4B
Revenue growth (YoY) +73.2%
Net margin -15.2%
Return on equity -59.6%
Free cash flow −₹3.2B FY2026
Operating margin -12.1%
More key figures
EPS (TTM) ₹-7.29
Net debt ₹11.2B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

ACL reported revenue of ₹4.4B in FY2026 versus ₹0 in FY2022. Reported net income was −₹672M in FY2026.

Revenue
FY22 ₹0
FY23 ₹0
FY24 ₹2.7B
FY25 ₹2.7B
FY26 ₹4.4B
Net income
FY22 −₹2.4B
FY23 ₹9.5B
FY24 −₹656M
FY25 −₹1.5B
FY26 −₹672M

Is ACL fairly valued? → Check now

Similar stocks

6 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
CRH plc CRH $106.52 $64.08 -40%
Holcim AG HCMLY $19.20 $8.68 -55%
Heidelberg Materials AG HEI €190.80 €134.98 -29%
Vulcan Materials Company VMC $281.38 $116.17 -59%
Martin Marietta Materials, Inc MLM $575.83 $135.46 -76%
UltraTech Cement Limited ULTRACEMCO ₹10,866 ₹4,589 -58%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is ACL (ACL) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹5.87 versus a price of ₹52.03 — about −89% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ACL?
Our model-based fair value for ACL is ₹5.87 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹52.03.
What is the quality score of ACL?
ACL has a Quality Score of 34/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of ACL (ACL)?
ACL reported trailing-twelve-month revenue of about ₹4.4B (latest available figure, as of Jul 3, 2026).
What is the net profit margin of ACL?
The net profit margin of ACL is about -15.2%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.